You have 9 free searches left this month | to do more
Showing 1 - 25 of
7,717 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
Q
Not yet recruiting
  • Malignant Melanoma
  • (no location specified)
2021-06-15
Jun 15, 2021
C
Terminated
  • Melanoma
  • Malignant Melanoma
  • Immunostimulating Interstitial Laser Thermotherapy
  • Stockholm, Sweden
    Karolinska University Hospital Solna
2021-07-02
Jul 2, 2021
Q
Not yet recruiting
  • Locally Advanced or Metastatic Acral Malignant Melanoma
  • Toripalimab and Anlotinib
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
2021-10-08
Oct 8, 2021
O
Recruiting
  • Melanoma
  • Biospecimen Collection
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-10-15
Oct 15, 2021
C
Recruiting
  • Malignant Melanoma
  • Angiosarcoma
  • CICS-1 (investigational device),SPM-011(investigational drug)
  • Chuo Ku, Tokyo, Japan
    National Cancer Center Hospital
2021-08-02
Aug 2, 2021
W
Recruiting
  • Melanoma
  • Wuhan, Hubei, China
    China, Hubei Province
2022-02-10
Feb 10, 2022
U
Active, not recruiting
  • Malignant Melanoma
  • Oslo, Norway
    Oslo University Hospital, Radiumhospitalet
2021-05-14
May 14, 2021
B
Completed
  • Melanoma
    • Chiyoda-ku, Tokyo, Japan
    • +1 more
    2022-02-11
    Feb 11, 2022
    L
    Recruiting
    • Malignant Melanoma
    • delolimogene mupadenorepvec
    • atezolizumab
    • Los Angeles, California
    • +2 more
    2022-04-04
    Apr 4, 2022
    F
    Recruiting
    • Malignant Melanoma
    • Hangzhou, Zhejiang, China
      Department of Medical Onocology, First Affiliated Hospital of Zh
    2021-05-10
    May 10, 2021
    M
    Recruiting
    • Fecal Microbiota Transplantation
    • +2 more
    • Allogenic Fecal Microbiota Transplantation
    • Autologous Fecal Microbiota Transplantation
    • Graz, Austria
      Medical University of Graz
    2021-10-11
    Oct 11, 2021
    Y
    Not yet recruiting
    • SCLC
    • +2 more
    • GD2-SADA:177Lu-DOTA Complex
    • (no location specified)
    2022-01-05
    Jan 5, 2022
    D
    Not yet recruiting
    • Malignant Melanoma
    • +4 more
    • (no location specified)
    2022-03-31
    Mar 31, 2022
    M
    Terminated
    • Melanoma
    • Essen, Germany
    • +3 more
    2021-09-28
    Sep 28, 2021
    U
    Completed
    • Melanoma
    • +4 more
    • therapeutic conventional surgery
    • +3 more
    • Orange, California
      Chao Family Comprehensive Cancer Center
    2020-12-30
    Dec 30, 2020
    A
    Active, not recruiting
    • Unresectable Stage IIIB-IV Malignant Melanoma
    • Talimogene laherparepvec
    • Nagoya-shi, Aichi, Japan
    • +8 more
    2021-12-02
    Dec 2, 2021
    M
    Completed
    • Malignant Melanoma
      • Graz, Styria, Austria
        Medical University of Graz
      2020-11-23
      Nov 23, 2020
      H
      Completed
      • Malignant Melanoma
      • patient with melanoma pre transplantation
      • Lyon, Rhone, France
        service de dermatologie - hopital Edouard Herriot
      2021-12-09
      Dec 9, 2021
      N
      Completed
      • Malignant Melanoma
      • Recurrent Melanoma
      • (no location specified)
      2020-10-18
      Oct 18, 2020
      B
      Completed
      • Malignant Melanoma Stage III
      • Malignant Melanoma Stage IV
      • TriMix-DC and ipilimumab
      • Jette, Brabant, Belgium
        UZ Brussel
      2021-03-24
      Mar 24, 2021
      U
      Active, not recruiting
      • Malignant Melanoma
      • Santa Monica, California
      • +3 more
      2021-05-20
      May 20, 2021
      S
      Terminated
      • Metastatic Malignant Melanoma
      • Dendritic cells - transfected with hTERT-, survivin- and tumor cell derived mRNA + ex vivo T cell expansion and reinfusion
      • Temozolomide
      • Oslo, Montebello, Norway
        The Norwegian Radium Hospital, Department of Clinical Cancer Res
      2021-02-23
      Feb 23, 2021
      U
      Recruiting
      • Cutaneous Malignant Melanoma
      • Vitamin D
      • arachides oleum raffinatum
      • Edegem, Belgium
      • +3 more
      2020-11-04
      Nov 4, 2020
      F
      Recruiting
      • Malignant Melanoma
      • Camrelizumab for injection
      • Shanghai, Shanghai, China
      • +1 more
      2020-12-20
      Dec 20, 2020